Table 3.

Expression of CD2 and other surface markers on cultured MC progenitors

mAbReactive antigenReactivity of mAb with cultured MCs on various days
Day 21Day 42Day 63
SK3 CD4 − − − 
L17F12 CD5 − − − 
7G3 CD123/IL-3Rα − − − 
9F5 CD123/IL-3Rα − − − 
YB5.B8 CD117/KIT 
L178 CD44/Pgp-1 
1C3 CD58/LFA-3 
T11 CD2/LFA-2 − − − 
S5.2 CD2/LFA-2 − − − 
RPA-2.10 CD2/LFA-2 − − − 
6F10.3 CD2/LFA-2 − − − 
39C1.5 CD2/LFA-2 − − − 
VIT13 CD2R/LFA-2 − − − 
mAbReactive antigenReactivity of mAb with cultured MCs on various days
Day 21Day 42Day 63
SK3 CD4 − − − 
L17F12 CD5 − − − 
7G3 CD123/IL-3Rα − − − 
9F5 CD123/IL-3Rα − − − 
YB5.B8 CD117/KIT 
L178 CD44/Pgp-1 
1C3 CD58/LFA-3 
T11 CD2/LFA-2 − − − 
S5.2 CD2/LFA-2 − − − 
RPA-2.10 CD2/LFA-2 − − − 
6F10.3 CD2/LFA-2 − − − 
39C1.5 CD2/LFA-2 − − − 
VIT13 CD2R/LFA-2 − − − 

Cord blood CD34+ MNCs were cultured as described in the text. After 21, 42, and 63 days, cultured MCs were examined for surface marker expression by flow cytometry. Antibodies against various cytokine receptors and CD2/LFA-2 were applied. Identical results were obtained with MCs cultured in both culture conditions: SCF+IL-6, SCF+IL-4+IL-6+IL-10.